Business
Response to Media Comment
Response to Media Comment.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 8954W AorTech International PLC 20 November 2017 \n\nAorTech International plc\n(\"AorTech\"or the \"Company\")\n \nResponse to Media comment \n \nAorTech International plc (AIM: AOR), the biomaterials and medical device IP company, notes the recent Media comment regarding the Company's ongoing litigation and confirms that the following joint motion was recently filed in the Utah Court by AorTech and the Foldax Defendants (as defined below):\n \n\"Plaintiff AorTech International plc (\"AorTech\") and Defendants Frank Maguire, Kenneth A. Charhut, Foldax Inc., and Folda LLC (collectively, \"the Foldax Defendants\"), through counsel, hereby provide notice that the parties have reached a settlement in principle to resolve all claims in this case.\n \nAorTech and the Foldax Defendants jointly move the Court to stay all proceedings and deadlines in this case as the parties continue these productive settlement negotiations. If these negotiations are successful, the parties will file a stipulated motion to dismiss with prejudice. If the parties are unable to successfully negotiate a settlement, the parties will provide notice to the Court and ask that the stay be lifted.\"\n \nAorTech will make a further announcement in due course.\n \nFor further information contact:\n \nAorTech International plc Tel: +44 (0)7730 718296 \nBill Brown, Chairman \n \nStockdale Securities Limited &nb...